Angela Allen

Principal, Expert Insights Products
AlphaSense

Louis Botha

Director of Product, GenAI
AlphaSense

Michelle Brophy

Director of Research
AlphaSense

Prior to joining AlphaSense, Michelle spent 3 years as the Strategist for TMT at Guidepoint Insights. Prior to this, Michelle spent 18 years on the buy side, in both portfolio manager and senior equity analyst roles, at Hilltop Park Capital and Kingdon Capital Management. Michelle has her BA from Bucknell University and resides in New York City.

Brett Caughran

Head Trainer
Fundamental Edge

Brett brings 13 years of buy-side experience across Maverick, D.E. Shaw, Citadel, Two Sigma, and Schonfeld, along with experience teaching FIN 494, “The Hedge Fund Analyst Process,” at Arizona State University. He founded Fundamental Edge in 2022 to redefine buy-side training and now advises hedge funds on applying AI to investment research, analyst workflows, and firmwide research processes.

Alanna Crank

COO of Global Equity Research
Jefferies

Michael Eastwood

Director of Americas Research
Jefferies

Michael joined Jefferies in 2012 from Morgan Stanley, where he was Director of North American Fixed Income Research and, prior to that, Associate Director of North American Equity Research and Head of US Corporate Access. Prior to moving to the US in 2009, he was a ranked European Chemical Analyst at Morgan Stanley for 10 years and at Dresdner Kleinwort Benson for 5 years based in London. Mr. Eastwood received a MA from the University of Aberdeen.

Sina Falaki

Sr. Director Solution Marketing
AlphaSense

Sina Falaki is the Sr. Director of Solutions Marketing at AlphaSense, where he focuses on helping companies use AI and market intelligence to make faster, more informed decisions. He works closely with customers to understand how leading teams approach competitive intelligence, corporate strategy, finance, and life sciences research, then helps translate those workflows into practical solutions within AlphaSense. Prior to AlphaSense, Sina held marketing leadership roles at Motive and Procore, helping both companies scale through periods of rapid growth and transformation.

Sarah Flaccavento

Senior Vice President, Strategic Initiatives
AlphaSense

Emma Griffin

Senior Director of Product, Enterprise Intelligence
AlphaSense

Dan Hamilton

SVP, Corporate Strategy
Salesforce

Dan Hamilton is SVP, Corporate Strategy at Salesforce, where he leads a team of competitive intelligence experts helping the business understand the market and stay ahead of the competition. His organization translates complex industry and market trends into clear strategy and tactics, informing decisions and driving results across sales, product, marketing, and beyond. Dan is passionate about building a culture grounded in truth, and turning insight into decisive action that helps create competitive advantage in the market.

Sarah Hoffman

Director of AI Thought Leadership
AlphaSense

Sarah is Director of AI Thought Leadership at AlphaSense, where she explores artificial intelligence trends that will matter most to AlphaSense’s customers. Previously, Sarah was Vice President of AI and ML Research for Fidelity Investments, led FactSet’s ML and Language Technology team and worked as an Information Technology Analyst at Lehman Brothers. With a career spanning two decades in AI, ML, natural language processing, and other technologies, Sarah’s expertise has been featured in The Wall Street Journal, CNBC, VentureBeat, and on Bloomberg TV. Sarah holds a master's degree from Columbia University in computer science with a focus on natural language processing, and a B.B.A. from Baruch College in computer information systems. Sarah is based in New York.

Mark Jones

Senior Director, Customer Education
AlphaSense

Mark Jones has been training customers on how to get the most out of the AlphaSense platform for more than 4 years. As Director of Customer Education, he and his team work every day to help all users make better decisions faster.

Hala Kosyura

Managing Director, Portfolio Strategy
Canada Pension Plan Investment Board

Hala is part of Active Equities’ Portfolio Strategy team. She supports multi-year portfolio development, department-level strategic initiatives, and portfolio management efforts in alignment with Active Equities' overall investment signals. Hala also plays a key role in capital allocation, portfolio design, and in select external manager relationships in collaboration with EPM, with a focus on knowledge transfer. She joined CPP Investments in 2018 as part of the Portfolio Value Creation group, where she led value creation initiatives across Real Assets, Private Equity, and Credit investment holdings. Prior to CPP Investments, Hala spent over a decade at Boston Consulting Group, advising global financial services and technology companies on strategy and large-scale transformation. Hala holds an MBA from the Rotman School of Management at University of Toronto and is a holder of the ICD.D designation.

Sara Mallatt

Director of Healthcare Research
AlphaSense

Sara has nearly 20 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

Jazmin Medina

Investment Partner
D.E. Shaw Ventures

Jazmin Medina is an Investment Partner within D. E. Shaw Ventures, the D. E. Shaw group’s post-seed and growth equity investment team, which is part of the firm's Fundamental Equities investment unit. In that capacity, Ms. Medina contributes to the research and analysis of investments in emerging private companies. Prior to joining the D. E. Shaw group in 2024, she was a founding member of the investment team at NewView Capital, a venture capital firm based in the San Francisco Bay Area, where she built out that firm’s investment portfolio in the consumer, fintech, and SaaS market segments. Prior to that, Ms. Medina was co-founder and chief operating officer of Bundler TV, a technology and media startup firm. She began her career at The Goldman Sachs Group, Inc. in New York, where she worked in the investment banking division and covered firms in the financial and health care sectors. Ms. Medina holds an M.B.A. from Harvard Business School, where she is a member of the alumni board. She received a B.S. in finance from Arizona State University’s W. P. Carey School of Business and serves on the board of directors of the ASU Foundation.

Cindy Olsen

Chief Strategy Officer
sweetgreen

Cindy Olsen has over 20 years of experience in strategy, investor relations, and consumer investing. She is recognized for connecting strategic vision to value creation and driving disciplined decision-making that delivers sustainable growth, which she will bring to advancing Sweetgreen’s mission of connecting people to real food. Cindy joins Sweetgreen from Chipotle Mexican Grill, where she served as Head of Investor Relations and Strategy. At Chipotle, Cindy worked closely with the executive team to evolve the long-term strategy and connect it to value creation, bridging the priorities of team members, guests, and shareholders. During her tenure, Cindy earned consecutive, multi-year top-ranked honors as an Investor Relations Professional from Extel, as well as a ‘TopGun’ designation from Brendan Wood International. Prior to Chipotle, Cindy served as Managing Director and Equity Research Analyst at Nuveen and Franklin Templeton, where she spent a total of 17 years covering public and private companies across the consumer sector, giving her a unique investor’s perspective on what makes exceptional brands truly enduring, which she now brings directly to Sweetgreen. Cindy holds the Chartered Financial Analyst (CFA) designation and earned her undergraduate degree from Stanford University.

Chintan Oza

Executive Director, Enterprise Strategy
Merck

Christopher Salatto

Head of Competitive Intelligence
Pfizer Inc

Chris serves as Head of Competitive Intelligence at Pfizer. In this role he leads a global team of experts skilled at building a comprehensive view of the pharma environment, from the asset through sector levels, and integrating these knowledge and insights into every level of decision-making at Pfizer - from discovery projects to the board of directors. Earlier, as Director of Competitive Intelligence, Corporate and Internal Medicine, Chris guided Pfizer's Corporate Intelligence function, providing the company's executive leadership team and board of directors with insights into the industry's macro-competitive landscape. During this period, he also provided expertise and strategic analysis to Pfizer's commercial teams in oncology, internal medicine, and infectious diseases. Formerly, Chris was a Principal Scientist in Pfizer’s Internal Medicine Research Unit, leading a team of scientists to execute drug discovery projects from early discovery through Phase 1 clinical trials in the areas of diabetes, liver diseases and diabetic nephropathy. Over his 16 years with the unit, he contributed biology and drug discovery expertise to publications in the areas of atherosclerosis, cardiac failure, diabetes, kidney disease, muscle wasting, osteoporosis, and muscular dystrophy. He started his pharmaceutical career as a research assistant and one of the first employees of La Jolla, CA-based Acadia Pharmaceuticals, working to advance preclinical programs in glaucoma and neurodegeneration. Chris received a BA in Biology and Chemistry from the University of Vermont, and has earned master’s degrees in Business Administration, Regulatory Affairs, and Biology from the University of Rhode Island, Temple University’s School of Pharmacy, and Brown University. He lives in Connecticut with his wife and two teenage daughters.

Ted Seides

Host
Capital Allocators

Ted is the founder of Capital Allocators, a platform that seeks to compound knowledge and relationships with asset owners and investment firms. He launched the Capital Allocators podcast in 2017. The show reached 20 million downloads in August 2024 and has been recognized as the top institutional investing podcast. Ted created Capital Allocators Summits alongside Rahul Moodgal to bring together industry leaders, Capital Allocators University for rising professionals to learn key investment skills, Capital Allocators Advisory to work with managers on business strategy, and Capital Allocators Coaching with a team of retired asset management executives. Ted previously worked under David Swensen at the Yale Investments Office, invested directly at three of Yale’s managers, co-founded and served as Co-CIO of Protégé Partners, and made a famous bet with Warren Buffett. He has authored three investment books. Ted graduated Cum Laude from Yale University and received an MBA from Harvard Business School.

Xavier Smith

Director of Research, E&I
AlphaSense

Xavier serves as the Director of Research, Energy and Industrials at AlphaSense. Before joining AlphaSense, Xavier worked as an equity portfolio manager at various firms including Goldman Sachs, and Guggenheim. Xavier has equity market experience in London as well as New York. Xavier received an MBA from the Wharton School and a BA from Tulane University.

Linda Stacy

Director, Information and Research Center
L.E.K. Consulting

Linda Stacy is Director of the U.S. Information & Research Center at L.E.K. Consulting, where she leads research and information services that support consulting teams across industries. With more than 20 years of experience, she oversees the evaluation and delivery of trusted information resources, helping teams identify authoritative sources, assess emerging technologies, and ensure high-quality intelligence informs client decisions.

Yasuhiro Tsukimi

Assistant Division Director, Innovative Drug Discovery Division
ASKA Pharmaceutical Co., Ltd.

Dr. Yasuhiro Tsukimi is an accomplished R&D leader currently serving as the Deputy Head of the Innovative Drug Discovery Division. Bringing over 30 years of pharmaceutical experience, his career includes a distinguished 16-year tenure at Takeda Pharmaceutical Company, where he directed drug discovery units for gastroenterology and inflammation. In addition to earlier senior scientific roles at Bayer Yakuhin and Shin Nippon Biomedical Laboratories, Dr. Tsukimi actively advances the broader scientific community as a Board Member for both the Japanese Pharmacological Society and the HAB Research Institute.

Pieter VanIperen

Chief Information Security Officer
AlphaSense

Daniel Wolf

Product Lead, Add-Ins
AlphaSense